OR WAIT null SECS
© 2022 MJH Life Sciences and Optometry Times. All rights reserved.
© 2022 MJH Life Sciences™ and Optometry Times. All rights reserved.
Optometrists must identify and mitigate complications for this patient base.
Experts answer clinicians’ common questions on treating patients.
Justin Schweitzer, OD, shares key highlights from his presentation titled, "The OD's Role in the Management of MIGS in 2022," where he explores earlier intervention for glaucoma patients.
Reducing the burden of drops can improve patients’ QOL and prevent progression of glaucoma.
Know the facts, not misinformation, about slowing or halting disease progression
Find out the latest on technologies, techniques, and treatments
Ocuphire submits new drug application for eye drops for reversal of mydriasis
Getting started: methods of initial scleral lens selection
What is presbyopia?
Case report: Combination treatment proves effective for choroidal metastasis from breast cancer patient